Our study demonstrates that the probiotic effect of the wzy mutant of colitis-associated E. coli NI1429 requires host immune factors including C3, suggesting that effective use of probiotic strains based on the wzy mutation requires the presence of a normal immune system and in particular an intact complement system. This evidence concerns the gene C3 and colitis.